Wells Fargo’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-142,783
Closed -$24.6M 7677
2021
Q3
$24.6M Sell
142,783
-42,032
-23% -$7.23M 0.01% 1466
2021
Q2
$23.2M Buy
184,815
+59,120
+47% +$7.42M 0.01% 1531
2021
Q1
$17M Sell
125,695
-12,618
-9% -$1.71M ﹤0.01% 1736
2020
Q4
$17.7M Buy
138,313
+21,841
+19% +$2.79M ﹤0.01% 1631
2020
Q3
$13.1M Buy
116,472
+56,826
+95% +$6.39M ﹤0.01% 1691
2020
Q2
$5.68M Buy
59,646
+22,005
+58% +$2.1M ﹤0.01% 2327
2020
Q1
$3.38M Sell
37,641
-10,428
-22% -$937K ﹤0.01% 2516
2019
Q4
$2.55M Buy
48,069
+11,396
+31% +$604K ﹤0.01% 3120
2019
Q3
$1.45M Buy
36,673
+3,083
+9% +$122K ﹤0.01% 3539
2019
Q2
$1.38M Sell
33,590
-1,669
-5% -$68.6K ﹤0.01% 3596
2019
Q1
$1.64M Buy
35,259
+1,524
+5% +$71K ﹤0.01% 3492
2018
Q4
$1.47M Sell
33,735
-2,164
-6% -$94.2K ﹤0.01% 3479
2018
Q3
$2.06M Sell
35,899
-102
-0.3% -$5.84K ﹤0.01% 3342
2018
Q2
$1.75M Buy
36,001
+1,348
+4% +$65.4K ﹤0.01% 3518
2018
Q1
$1.36M Buy
34,653
+1,287
+4% +$50.3K ﹤0.01% 3626
2017
Q4
$1.42M Sell
33,366
-9,878
-23% -$419K ﹤0.01% 3606
2017
Q3
$1.61M Buy
43,244
+5,247
+14% +$196K ﹤0.01% 3421
2017
Q2
$1.15M Sell
37,997
-41,465
-52% -$1.26M ﹤0.01% 3572
2017
Q1
$2.1M Buy
79,462
+40,910
+106% +$1.08M ﹤0.01% 3132
2016
Q4
$983K Buy
38,552
+15,294
+66% +$390K ﹤0.01% 3635
2016
Q3
$842K Sell
23,258
-225
-1% -$8.15K ﹤0.01% 3521
2016
Q2
$798K Sell
23,483
-434
-2% -$14.7K ﹤0.01% 3566
2016
Q1
$630K Sell
23,917
-347
-1% -$9.14K ﹤0.01% 3647
2015
Q4
$1.18M Buy
24,264
+17,758
+273% +$866K ﹤0.01% 3305
2015
Q3
$162K Buy
6,506
+266
+4% +$6.62K ﹤0.01% 4427
2015
Q2
$198K Buy
6,240
+2,512
+67% +$79.7K ﹤0.01% 4474
2015
Q1
$142K Buy
3,728
+2,036
+120% +$77.6K ﹤0.01% 4447
2014
Q4
$66K Buy
1,692
+399
+31% +$15.6K ﹤0.01% 4741
2014
Q3
$39K Sell
1,293
-513
-28% -$15.5K ﹤0.01% 4884
2014
Q2
$62K Buy
1,806
+998
+124% +$34.3K ﹤0.01% 4765
2014
Q1
$28K Sell
808
-796
-50% -$27.6K ﹤0.01% 4998
2013
Q4
$64K Buy
+1,604
New +$64K ﹤0.01% 4596